Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Theophylline for Olfaction in ESRD
NCT02479451Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Oct 2015
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of theophylline in Olfactory dysfunction, sponsored by Massachusetts General Hospital. Started Oct 2015; status: completed.
02
Drugs
theophylline
03
Conditions
Olfactory dysfunction
Beyond the preview
Go deeper on NCT02479451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02479451.